Janssen Sues Samsung Bioepis to Block Remicade Biosimilar
Janssen has filed suit in a New Jersey federal court, hoping to delay a recently approved Remicade biosimilar from entering the market — while the biosimilar’s developer, Samsung Bioepis, bets…